155 related articles for article (PubMed ID: 21655642)
1. Histopathological and immunohistochemical features of gastrointestinal stromal tumors.
Fülöp E; Marcu S; Borda A; Moldovan C; Fülöp EF; Loghin A; Pávai Z
Rom J Morphol Embryol; 2011; 52(2):555-62. PubMed ID: 21655642
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stromal tumors: review on morphology, diagnosis and management.
Fülöp E; Marcu S; Milutin D; Borda A
Rom J Morphol Embryol; 2009; 50(3):319-26. PubMed ID: 19690756
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
Miettinen M; Lasota J
Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).
Miettinen M; Sobin LH; Sarlomo-Rikala M
Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
8. Canine gastrointestinal stromal tumors: immunohistochemical expression of CD34 and examination of prognostic indicators including proliferation markers Ki67 and AgNOR.
Gillespie V; Baer K; Farrelly J; Craft D; Luong R
Vet Pathol; 2011 Jan; 48(1):283-91. PubMed ID: 20826846
[TBL] [Abstract][Full Text] [Related]
9. Revision of gastrointestinal mesenchymal tumors.
Sornmayura P; Howannapakorn J; Karnsombut P
J Med Assoc Thai; 2009 Jan; 92(1):87-95. PubMed ID: 19260248
[TBL] [Abstract][Full Text] [Related]
10. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
Sarlomo-Rikala M; Kovatich AJ; Barusevicius A; Miettinen M
Mod Pathol; 1998 Aug; 11(8):728-34. PubMed ID: 9720500
[TBL] [Abstract][Full Text] [Related]
11. Revision of gastrointestinal mesenchymal tumours with CD117.
de Schipper JP; Liem RS; van den Ingh HF; van der Harst E
Eur J Surg Oncol; 2004 Nov; 30(9):959-62. PubMed ID: 15498641
[TBL] [Abstract][Full Text] [Related]
12. A clinical and immunohistochemical study of gastrointestinal stromal tumours.
Khoo JJ; Gunn A
Malays J Pathol; 2005 Jun; 27(1):9-16. PubMed ID: 16676687
[TBL] [Abstract][Full Text] [Related]
13. [Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy].
Coindre JM; Emile JF; Monges G; Ranchère-Vince D; Scoazec JY
Ann Pathol; 2005 Oct; 25(5):358-85; quiz 357. PubMed ID: 16498290
[TBL] [Abstract][Full Text] [Related]
14. [Expression and gene mutation of phospho-platelet derived growth factor receptor alpha and C-kit in gastrointestinal and extra-gastrointestinal stromal tumors].
Tang M; Li DQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):80-3. PubMed ID: 18197502
[TBL] [Abstract][Full Text] [Related]
15. [Gastrointestinal stromal tumor: a clinicopathological study of 74 cases].
Yang QC; Ji XH; Shen Y; Han F; Zhang XJ; Liu HB
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):6-10. PubMed ID: 15796874
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases.
Herawi M; Montgomery EA; Epstein JI
Am J Surg Pathol; 2006 Nov; 30(11):1389-95. PubMed ID: 17063078
[TBL] [Abstract][Full Text] [Related]
17. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract.
Rossi G; Valli R; Bertolini F; Marchioni A; Cavazza A; Mucciarini C; Migaldi M; Federico M; Trentini GP; Sgambato A
Histopathology; 2005 May; 46(5):522-31. PubMed ID: 15842634
[TBL] [Abstract][Full Text] [Related]
18. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall.
Pauwels P; Debiec-Rychter M; Stul M; De Wever I; Van Oosterom AT; Sciot R
Histopathology; 2005 Jul; 47(1):41-7. PubMed ID: 15982322
[TBL] [Abstract][Full Text] [Related]
19. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
20. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]